• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复合二元终点的多重性调整

Multiplicity adjustment for composite binary endpoints.

作者信息

Rauch Geraldine, Kieser M

机构信息

Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.

出版信息

Methods Inf Med. 2012;51(4):309-17. doi: 10.3414/ME11-01-0044. Epub 2012 Apr 24.

DOI:10.3414/ME11-01-0044
PMID:22525969
Abstract

BACKGROUND

Binary composite outcome measures are increasingly used as primary endpoints in clinical trials. Composite endpoints combine several events of interest within a single variable. However, as the effect observed for the composite does not necessarily reflect the effects for the individual components, it is recommended in the literature to additionally evaluate each component separately.

OBJECTIVES

The task is to define an adequate multiple test procedure which focuses on the composite outcome measure but allows for a confirmatory interpretation of the components in case of large effects.

METHODS

In this paper, we determine the correlation matrix for a multiple binary endpoint problem of a composite endpoint and its components based on the normal approximation test statistic for rates. Thereby, we assume multinomial distributed components. We use this correlation to calculate the adjusted local significance levels. We discuss how to use our approach for a more informative formulation of the test problem. Our work is illustrated by two clinical trial examples.

RESULTS

By taking into account the special correlation structure between a binary composite outcome and its components, an adequate multiple test procedure to assess the composite and its components can be defined based on an approximate multivariate normal distribution without much loss in power compared to a test problem formulated exclusively for the composite.

CONCLUSIONS

By incorporating the correlation under the null hypotheses, the global power for the multiple test problem assessing both the composite and its components can be increased as compared to simple Bonferroni-adjustment. Thus, a confirmatory analysis of the composite and its components might be possible without a large increase in sample size as compared to a single endpoint problem formulated exclusively for the composite.

摘要

背景

二元复合结局指标在临床试验中越来越多地被用作主要终点。复合终点将多个感兴趣的事件合并在一个单一变量中。然而,由于观察到的复合效应不一定反映各个组成部分的效应,文献中建议额外分别评估每个组成部分。

目的

任务是定义一种适当的多重检验程序,该程序侧重于复合结局指标,但在效应较大时允许对各组成部分进行验证性解释。

方法

在本文中,我们基于率的正态近似检验统计量,确定复合终点及其组成部分的多重二元终点问题的相关矩阵。因此,我们假设各组成部分服从多项分布。我们使用这种相关性来计算调整后的局部显著性水平。我们讨论如何使用我们的方法对检验问题进行更具信息量的表述。我们的工作通过两个临床试验实例进行说明。

结果

通过考虑二元复合结局与其组成部分之间的特殊相关结构,可以基于近似多元正态分布定义一种适当的多重检验程序,以评估复合结局及其组成部分,与专门针对复合结局制定的检验问题相比,功效损失不大。

结论

通过在原假设下纳入相关性,与简单的Bonferroni调整相比,评估复合结局及其组成部分的多重检验问题的总体功效可以提高。因此,与专门针对复合结局制定的单一终点问题相比,在不大幅增加样本量的情况下,对复合结局及其组成部分进行验证性分析可能是可行的。

相似文献

1
Multiplicity adjustment for composite binary endpoints.复合二元终点的多重性调整
Methods Inf Med. 2012;51(4):309-17. doi: 10.3414/ME11-01-0044. Epub 2012 Apr 24.
2
Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework.在竞争风险框架下规划和评估具有复合首次事件时间终点的临床试验。
Stat Med. 2013 Sep 20;32(21):3595-608. doi: 10.1002/sim.5798. Epub 2013 Apr 2.
3
Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.易于应用的多重检验程序,以改善对具有复合终点的临床试验的解读。
Int J Cardiol. 2014 Jul 15;175(1):126-32. doi: 10.1016/j.ijcard.2014.04.267. Epub 2014 May 9.
4
Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes.具有多个相关二元结局的临床试验中复合终点的贝叶斯设计与分析
Pharm Stat. 2013 Jul-Aug;12(4):207-12. doi: 10.1002/pst.1572. Epub 2013 Apr 29.
5
Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.具有离散检验统计量和超量考虑的适应性设计
Methods Inf Med. 2015;54(5):434-46. doi: 10.3414/ME14-02-0023. Epub 2015 Oct 2.
6
Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment.具有盲法选择二分类复合终点和样本量重新评估的适应性临床试验设计。
Biostatistics. 2023 Dec 15;25(1):237-252. doi: 10.1093/biostatistics/kxac040.
7
A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components.一种使用预期边际值和考虑组件之间相关性对复合二分类结局试验进行样本量估计的新方法。
Stat Med. 2019 May 20;38(11):1935-1956. doi: 10.1002/sim.8092. Epub 2019 Jan 13.
8
Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables.具有多个共同主要终点(包括混合的连续变量和二元变量)的临床试验中的样本量确定。
Biom J. 2012 Sep;54(5):716-29. doi: 10.1002/bimj.201100221. Epub 2012 Jul 25.
9
Simultaneous inference of a binary composite endpoint and its components.二元复合终点及其组成部分的同时推断。
J Biopharm Stat. 2017;27(1):56-69. doi: 10.1080/10543406.2016.1148704. Epub 2016 Feb 16.
10
Power and sample size when multiple endpoints are considered.考虑多个终点时的检验效能和样本量。
Pharm Stat. 2007 Jul-Sep;6(3):161-70. doi: 10.1002/pst.301.

引用本文的文献

1
Sample size estimation using a latent variable model for mixed outcome co-primary, multiple primary and composite endpoints.利用混合结局共同主要结局、多个主要结局和复合结局的潜变量模型进行样本量估计。
Stat Med. 2022 Jun 15;41(13):2303-2316. doi: 10.1002/sim.9356. Epub 2022 Feb 23.
2
Bin-CE: A comprehensive web application to decide upon the best set of outcomes to be combined in a binary composite endpoint.Bin-CE:一个全面的网络应用程序,用于决定在二进制复合终点中组合的最佳结果集。
PLoS One. 2018 Dec 13;13(12):e0209000. doi: 10.1371/journal.pone.0209000. eCollection 2018.
3
Opportunities and challenges of clinical trials in cardiology using composite primary endpoints.
使用复合主要终点的心脏病学临床试验的机遇与挑战。
World J Cardiol. 2015 Jan 26;7(1):1-5. doi: 10.4330/wjc.v7.i1.1.